Search Results 351-360 of 19230 for prostate cancer
A Study of Niraparib Combined with Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone to Treat Metastatic Prostate Cancer. Print ...
... prostate cancer. He treats all disorders of the Genitourinary tract, including prostate, bladder and kidney cancers with special focus on nerve-sparing ...
Natural Killer Cell Infiltration in Prostate Cancers Predict Improved Patient Outcomes. Prostate Cancer Prostatic Dis. 2024 Feb 28. [Epub ahead of print]
Prostate Cancer · Kidney Cancer · Bladder Cancer · Testicular Cancer · Melanoma ...
Clinical Trials · A Study of Abiraterone Acetate Plus Prednisone With or Without Abemaciclib in Participants With Prostate Cancer · More about research at Mayo ...
While it's not the same as prostate cancer, an enlarged prostate can cause significant quality of life issues. Dr. Scott Cheney, a Mayo Clinic urologist ...
Cancer Detection Rate and Abnormal Interpretation Rate of Prostate MRI Performed for Clinical Suspicion of Prostate Cancer. J Am Coll Radiol. 2024 Mar; 21 ...
prostate cancer are expected to be diagnosed this year. "The reality is that prostate cancer is the most commonly diagnosed solid malignancy in men," says ...
The study also seeks to further characterize (as possible) any other serious adverse reaction(s) in the long-term in adults with prostate cancer who received at ...
... prostate cancer, expanding active surveillance and biomarker development. PSMA therapy uses a radioactive material to kill prostate cancer cells.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Benefactor support fuels Mayo Clinic’s groundbreaking research. Make a gift today to help us save lives.